Smriti Sharma1, Richard E Davis2, Shweta Srivastva1, Susanne Nylén3, Shyam Sundar1, Mary E Wilson1,4. 1. Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India. 2. Interdisciplinary Program in Immunology, University of Iowa. 3. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden. 4. Departments of Internal Medicine and Microbiology, University of Iowa and the Veterans' Affairs Medical Center, Iowa City.
Abstract
BACKGROUND: Visceral leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and impaired protective T-cell responses against the parasite. METHODS: Peripheral blood leukocytes from 105 subjects with VL and healthy control subjects from the endemic region of Muzaffarpur, Bihar, India, were compared using flow cytometry and reverse-transcriptase quantitative polymerase chain reaction. Findings were correlated with clinical data. RESULTS: An expanded population of low-density neutrophils that expressed HLA-DR, CD80 and CD86 was observed in subjects with VL. This neutrophil population contracted after successful treatment of disease. Plasma from patients with acute VL was able to induce similar high-level HLA-DR expression in neutrophils from healthy subjects. HLA-DR+ neutrophils from subjects with VL did not stimulate T-cell proliferation, but they did express higher programmed cell death ligand-1 (PDL1) than other neutrophils, and lymphocytes of the same subjects expressed high programmed cell death 1 (PD1). CONCLUSIONS: Patients with acute VL have expanded circulating low-density neutrophils expressing markers of antigen presentation, which diminish after treatment. Development of HLA-DR+ neutrophils is stimulated, at least in part, by components of plasma from patients with acute disease. Although we found no evidence that they act as antigen-presenting cells, these neutrophils expressed markers implicating a role in T-cell exhaustion. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
BACKGROUND:Visceral leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and impaired protective T-cell responses against the parasite. METHODS: Peripheral blood leukocytes from 105 subjects with VL and healthy control subjects from the endemic region of Muzaffarpur, Bihar, India, were compared using flow cytometry and reverse-transcriptase quantitative polymerase chain reaction. Findings were correlated with clinical data. RESULTS: An expanded population of low-density neutrophils that expressed HLA-DR, CD80 and CD86 was observed in subjects with VL. This neutrophil population contracted after successful treatment of disease. Plasma from patients with acute VL was able to induce similar high-level HLA-DR expression in neutrophils from healthy subjects. HLA-DR+ neutrophils from subjects with VL did not stimulate T-cell proliferation, but they did express higher programmed cell death ligand-1 (PDL1) than other neutrophils, and lymphocytes of the same subjects expressed high programmed cell death 1 (PD1). CONCLUSIONS:Patients with acute VL have expanded circulating low-density neutrophils expressing markers of antigen presentation, which diminish after treatment. Development of HLA-DR+ neutrophils is stimulated, at least in part, by components of plasma from patients with acute disease. Although we found no evidence that they act as antigen-presenting cells, these neutrophils expressed markers implicating a role in T-cell exhaustion. Published by Oxford University Press for the Infectious Diseases Society of America 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Authors: N A Fanger; C Liu; P M Guyre; K Wardwell; J O'Neil; T L Guo; T P Christian; S P Mudzinski; E J Gosselin Journal: Blood Date: 1997-06-01 Impact factor: 22.113
Authors: Nathan C Peters; Jackson G Egen; Nagila Secundino; Alain Debrabant; Nicola Kimblin; Shaden Kamhawi; Phillip Lawyer; Michael P Fay; Ronald N Germain; David Sacks Journal: Science Date: 2008-08-15 Impact factor: 47.728
Authors: Christabelle J Darcy; Gabriela Minigo; Kim A Piera; Joshua S Davis; Yvette R McNeil; Youwei Chen; Alicia D Volkheimer; J Brice Weinberg; Nicholas M Anstey; Tonia Woodberry Journal: Crit Care Date: 2014-08-01 Impact factor: 9.097
Authors: Nayara I Medeiros; Rafael T Mattos; Carlos A Menezes; Rafaelle C G Fares; André Talvani; Walderez O Dutra; Fabrício Rios-Santos; Rodrigo Correa-Oliveira; Juliana A S Gomes Journal: Eur J Nutr Date: 2017-07-22 Impact factor: 5.614
Authors: Laiana A Barbosa; Paloma P Fiuza; Letícia J Borges; Fellipe A Rolim; Mayara B Andrade; Nivea F Luz; Graziele Quintela-Carvalho; Jonilson B Lima; Roque P Almeida; Francis K Chan; Marcelo T Bozza; Valeria M Borges; Deboraci B Prates Journal: Front Immunol Date: 2018-08-14 Impact factor: 7.561
Authors: Suênia da C Gonçalves-de-Albuquerque; Rômulo Pessoa-E-Silva; Lays A M Trajano-Silva; Tayná Correia de Goes; Rayana C S de Morais; Cíntia N da C Oliveira; Virgínia M B de Lorena; Milena de Paiva-Cavalcanti Journal: Front Immunol Date: 2017-10-30 Impact factor: 7.561
Authors: Hossam Ebaid; Bahaa Abdel-Salam; Iftekhar Hassan; Jameel Al-Tamimi; Alli Metwalli; Ahmed Rady; Ibrahim M Alhazza Journal: Biomed Res Int Date: 2020-07-13 Impact factor: 3.411